Atlas Trials

Sorafenib VS TACE in HCC Patients With Portal Vein Invasion

Clinical trial NCT01480817 · TERMINATED

Trial details

NCT number
NCT01480817
Sponsor
Seoul National University Hospital
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2012-06-01
Primary completion
2015-12-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.